References
- Gaynon PS, Angiolillo AL, Carroll WL, et al. Long-term results of the Children's Cancer Group studies for childhood acute lymphoblastic leukemia 1983–2002: a Children's Oncology Group report. Leukemia. 2010:24:285–297.
- Salzer WL, Devidas M, Carroll WL, et al. Long-term results of the Pediatric Oncology Group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the Children's Oncology Group. Leukemia. 2010:24:355–370.
- Malempati S, Gaynon PS, Sather H, et al. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group Study CCG-1952. J Clin Oncol. 2007:25:5800–5807.
- Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia. 2008:22:2142–2150.
- Jorgensen M, Shankar A, Aabideen Z, et al. The role of routine surveillance for silent central nervous system relapse in children with acute lymphoblastic leukaemia. Br J Haematol. 2012:159:368–370.
- Rogers PC, Bleyer WA, Coccia P, et al. Yield of unpredicted bone-marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia. A report from the Children's Cancer Study Group. Lancet. 1984:1:1320–1322.
- Gandhi M, Rao K, Chua S, et al. Routine blood counts in children with acute lymphoblastic leukaemia after completion of therapy: are they necessary? Br J Haematol. 2003:122:451–453.
- Gupta S, Crump HL, Alexander S. The utility of end-of-treatment bone marrow aspirates in pediatric acute lymphoblastic leukemia: a quality improvement project. Pediatr Blood Cancer. 2012:59:1305–1306.
- Hutt PJ, Sabio H, Gilchrist GS, et al. Childhood acute lymphoblastic leukemia: are routine end-of-therapy bone marrow and cerebrospinal fluid examinations necessary? Mayo Clin Proc. 1996:71:854–856.
- Rubnitz JE, Hijiya N, Zhou Y, et al. Lack of benefit of early detection of relapse after completion of therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2005:44:138–141.
- Komp DM, Fischer DB, Sabio H, et al. Frequency of bone marrow aspirates to monitor acute lymphoblastic leukemia in childhood. J Pediatr. 1983:102:395–397.
- Bleyer WA, Sather H, Hammond GD. Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-hodgkin's lymphoma: 1985. A report from the Children's Cancer Study Group. Cancer. 1986:58:590–594.
- Chessells JM. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol. 1998:102:423–438.
- Chessells JM, Veys P, Kempski H, et al. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol. 2003:123:396–405.
- Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse—the Children's Cancer Group experience. Cancer. 1998:82:1387–1395.
- Wheeler K, Richards S, Bailey C, et al. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical research council working party on childhood leukaemia. Br J Haematol. 1998:101:94–103.
- Barredo JC, Devidas M, Lauer SJ, et al. Isolated cns relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a Pediatric Oncology Group study. J Clin Oncol. 2006:24:3142–3149.
- Matloub Y, Lindemulder S, Gaynon PS, et al. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood. 2006:108:1165–1173.
- Ritchey AK, Pollock BH, Lauer SJ, et al. Improved survival of children with isolated cns relapse of acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1999:17:3745–3752.